Home » Topics » BioWorld Science

BioWorld Science
RSS

DelMar reports updated results from phase II study of VAL-083 in newly diagnosed GBM

Aug. 14, 2019

CureVac, Yale to jointly discover mRNA-based candidates for pulmonary diseases

Aug. 14, 2019

AC Immune partners with University of Pennsylvania to further study TDP-43

Aug. 14, 2019

Pharmadiall presents new coagulation factor Xa inhibitors

Aug. 14, 2019

SHR-1653 as a novel highly potent and selective OTR antagonist

Aug. 14, 2019

DS-39201083 is a new derivative of conolidine with superior analgesic activity

Aug. 14, 2019

Kezar Life Sciences initiates PRESIDIO and MARINA phase II studies of KZR-616

Aug. 14, 2019

New mGluR5 allosteric modulators discovered at Recordati Industria Chimica e Farmaceutica

Aug. 14, 2019

Medshine Discovery presents new antibacterials

Aug. 14, 2019

New beta-secretase inhibitors synthesized at Novartis

Aug. 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...